Skip to main content
Glama

get_bioactivity_assay_chemicals

get_bioactivity_assay_chemicals
Read-onlyIdempotent

Retrieve chemicals associated with a given bioactivity assay endpoint using its assay endpoint ID (aeid) to support toxicology screening and chemical hazard analysis.

Instructions

Get chemicals associated with an assay endpoint

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
aeidYesAssay endpoint ID

Output Schema

TableJSON Schema
NameRequiredDescriptionDefault
dataYesGeneric array schema used for MCP tools that return lists of records or scalar values.

Schema Changelog

Changes observed during successful MCP inspections.

  1. First observedv0.3.0

TDQS

C2.9/5.0
Behavior2/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint=true, idempotentHint=true, openWorldHint=true, and destructiveHint=false, covering the safety profile. The description adds no behavioral context beyond those annotations—no pagination, return shape, or scope details—so it contributes little on this dimension.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is a single efficient sentence with the resource front-loaded after the verb. It is appropriately sized for a simple lookup tool, though it omits any differentiating or usage context that could make it more informative.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness3/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a low-complexity, single-parameter lookup with an output schema and full annotation coverage, the description is minimally adequate. It does not need to explain return values, but it still lacks usage guidance and sibling differentiation, leaving a clear gap for an agent navigating many similar bioactivity tools.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

There is one required parameter (aeid) and schema description coverage is 100%, so the schema already fully documents it. The description says the input is an assay endpoint, which corroborates the schema but adds no syntax or format detail beyond it, matching the baseline of 3 when the schema does the heavy lifting.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose4/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a clear verb (get) and resource (chemicals associated with an assay endpoint), so an agent can tell what the tool returns. However, it does not distinguish itself from close siblings such as get_bioactivity_summary_by_aeid or get_bioactivity_data, which also operate on assay endpoints, so sibling differentiation is missing.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines2/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

There is no guidance on when to use this tool versus alternatives, nor any prerequisite or exclusion. The description only restates the purpose, leaving the agent to infer usage context from the name alone.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Deploy Server

Other Tools